A dominant mutation in a neuronal acetylcholine receptor subunit leads to motor neuron degeneration in Caenorhabditis elegans by Barbagallo, Belinda et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Student Publications Graduate School of Biomedical Sciences 
2010-10-20 
A dominant mutation in a neuronal acetylcholine receptor subunit 
leads to motor neuron degeneration in Caenorhabditis elegans 
Belinda Barbagallo 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_sp 
 Part of the Neuroscience and Neurobiology Commons 
Repository Citation 
Barbagallo B, Prescott HA, Boyle P, Climer J, Francis MM. (2010). A dominant mutation in a neuronal 
acetylcholine receptor subunit leads to motor neuron degeneration in Caenorhabditis elegans. GSBS 
Student Publications. https://doi.org/10.1523/JNEUROSCI.1515-10.2010. Retrieved from 
https://escholarship.umassmed.edu/gsbs_sp/1679 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Student 
Publications by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Cellular/Molecular
A Dominant Mutation in a Neuronal Acetylcholine
ReceptorSubunitLeads toMotorNeuronDegeneration
inCaenorhabditis elegans
Belinda Barbagallo, Hilary A. Prescott,* Patrick Boyle,* Jason Climer, andMichael M. Francis
Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
Inappropriate or excessive activation of ionotropic receptors can have dramatic consequences for neuronal function and, in many
instances, leads to cell death. In Caenorhabditis elegans, nicotinic acetylcholine receptor (nAChR) subunits are highly expressed in a
neural circuit that controlsmovement.Here, we show that heteromeric nAChRs containing the acr-2 subunit are diffusely localized in the
processes of excitatory motor neurons and act to modulate motor neuron activity. Excessive signaling through these receptors leads to
cell-autonomousdegenerationof cholinergicmotorneuronsandparalysis.C. elegansdoublemutants lacking calreticulinandcalnexin—
two genes previously implicated in the cellular events leading to necrotic-like cell death (Xu et al. 2001)—are resistant to nAChR-
mediated toxicity and possess normal numbers of motor neuron cell bodies. Nonetheless, excess nAChR activation leads to progressive
destabilization of themotor neuron processes and, ultimately, paralysis in these animals. Our results provide new evidence that chronic
activationof ionotropic receptors canhavedevastatingdegenerative effects inneuronsand reveal that ion channel-mediated toxicitymay
have distinct consequences in neuronal cell bodies and processes.
Introduction
Roles for ionotropic receptor-mediated signaling in the nervous
system extend far beyond a well characterized participation in
cell–cell communication at synapses. Ionotropic receptor activa-
tion is one of several key factors that influence cell survival in
developing and mature nervous systems. For example, signaling
through nicotinic acetylcholine receptors (nAChRs) promotes
the elimination of neurons in the developing avian autonomic
nervous system (Hruska andNishi, 2007;Hruska et al. 2009), and
inappropriate pharmacological activation of nAChRs in theCae-
norhabditis elegans nervous system leads to developmental arrest
(Ruaud and Bessereau, 2006). In the mature nervous system,
inappropriate or excessive ion channel activation can have dra-
matic consequences. Inmammals, hypoxic events, such as stroke,
lead to excitotoxic cell death as a consequence of excess glutamate
release and hyperexcitation of ionotropic glutamate receptors
(iGluRs) (Sattler and Tymianski, 2001). Likewise, mutations that
cause prolonged activation of nAChRs or iGluRs can lead to neu-
rodegeneration and cell death in organisms ranging from nema-
todes to mammals (Treinin and Chalfie, 1995; Zuo et al. 1997;
Heintz and Zoghbi, 2000; Orr-Urtreger et al. 2000; Labarca et al.
2001; Orb et al. 2004; Miwa et al. 2006). Excess ion channel acti-
vation is also a contributing factor in neurodegenerative diseases.
For example, the selective vulnerability of motor neurons to cell
death in amyotrophic lateral sclerosis (ALS) is believed to arise, at
least in part, from hyperactivation of calcium-permeable AMPA-
type iGluRs (Kwak and Weiss, 2006; Grosskreutz et al. 2010).
Interestingly, in variousmousemodels ofmotor neuron diseases,
including ALS, genetic manipulations that prevent the death of
motor neuron cell bodies are not successful in halting disease
progression (Sagot et al. 1995; Gould et al. 2006). This result
implies that ion channel hyperactivation may contribute to degen-
erative events that persist even under conditions when neuronal cell
death is attenuated. Shared features of ion channel-mediateddegen-
eration across these diverse receptor types and systems suggest
that aspects of this process may be broadly conserved across or-
ganisms (Driscoll and Gerstbrein, 2003). In most cases, however,
a cohesive picture of the cellular events that influence the pro-
gression toward cell death as a consequence of ion channel hy-
peractivation remains unclear.
Ionotropic receptor signaling and its contribution to neuro-
degeneration can be dissected in detail in the compact nervous
system of the nematodeCaenorhabditis elegans. Here, we provide
evidence that the non- nAChR subunit ACR-2 contributes to a
heteromeric receptor that is important for regulating the activity
of excitatorymotor neurons. A poremodification in ACR-2 leads
to loss of motor neurons and paralysis of the animal. Genetic
ablation of nAChR subunits that coassemble into a heteromeric
receptor complexwithACR-2 suppresses ACR-2(L/S) (where L/S
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is leucine-to serine substitution) toxicity. In addition, C. elegans
double mutants lacking two genes previously implicated in cal-
cium homeostasis and necrotic cell death (crt-1/calreticulin and
cnx-1/calnexin) are resistant to nAChR-mediated toxicity and
possess normal numbers of motor neuron cell bodies. Nonethe-
less, we observe a progressive degeneration of the motor neuron
processes that leads to paralysis in these animals. Thus, ion chan-




AChR subunit constructs. The full-length ACR-2::GFP transgene
(pDM1232) was generated by introducing the green fluorescent protein
(GFP) coding sequence in-frame into the sequence of an acr-2 genomic
fragment (3353 to 7776 bp relative to the translational start site)
encoding the intracellular loop between transmembrane domains TM3
and TM4. The full-length ACR-2(L/S) construct (pBB9) was generated
by PCR-based site directed mutagenesis using mutant primers and
pDM1232 as the template. The Pacr-2::ACR-12 cDNA (pHP3) and
Punc-47::ACR-12 cDNA (pBB25) constructs were generated by amplify-
ing the acr-12 cDNA from the expressed sequence tag yk1093d12 (gift
from Yuji Kohara, National Institute of Genetics, Mishima, Japan) using
sequence-specific primers designed to the start and stop of acr-12 and
subcloning it into the NheI/SacI sites of a plasmid containing an3.3 kb
promoter for the acr-2 gene or into a plasmid containing a 1.3 kb pro-
moter for the unc-47 gene.
Transcriptional reporters. The Punc-47::mCherry construct (pPRB5)
was generated by subcloning an AgeI/AatII fragment that contained the
full-length mCherry coding sequence into a vector containing a 1.3 kb
promoter for the unc-47 gene. The Pacr-2::GFP (pPRB19) construct was
generated by subcloning an AatII/BamHI fragment that contained an
3.3 kb promoter for the acr-2 gene into a vector containing the GFP
coding sequence.
C. elegans strains
C. elegans strains were grown on nematode growth medium (NGM)
plates with the OP50 strain of Escherichia coli at 22°C using standard
laboratory procedures. Wild-type animals are the N2 Bristol strain. All
transgenic strains were obtained by microinjection of plasmid DNA into
the germ line and data presented are from a single representative trans-
genic line unless noted otherwise. In all cases, lin-15(n765ts) mutants
were injected with the lin-15 rescuing plasmid (pL15EK; 30 ng/l) and
one or more of the following plasmids (30 ng/l): pBB9, pBB25,
pDM1232, pHP3, pPRB4, pPRB5, pPRB14, pPRB19. Multiple indepen-
dent extragenic lines were obtained for each transgenic strain. Stably
integrated lines were generated as necessary by x-ray integration and
outcrossed at least four times to wild type. The transgenic strain express-
ing the integrated ACR-2(L/S) transgene (ufIs25) was outcrossed 10
times to wild type. The following strains were used in this study: RB1559
acr-2(ok1887 ), IZ421 acr-12(ok367 ), RB2071 ced-3(ok2734 ), VC1801
cnx-1(ok2234 ), RB1021 crt-1(ok948), IZ74 unc-29(x29), CB904 unc-
38(e264 ), CB306 unc-50(e306 ), VC731 unc-63(ok1075), CB883 unc-
74(e883), IZ380 ufIs31, IZ814 ufIs25, IZ625 ufIs25;ufIs31, IZ790 ufIs49,
IZ627 ufIs42, LX949 vsIs48, IZ924 ufIs25;vsIs48, IZ950 ced-3(ok2734 );
ufIs25;vsIs48, IZ877 cnx-1(ok2234 );ufIs25;vsIs48, IZ926 crt-1(ok948);
ufIs25;vsIs48, IZ976 crt-1(ok948);cnx-1(ok2234 );ufIs25;vsIs48, IZ971
crt-1(ok948);cnx-1(ok2234 );vsIs48, IZ927 crt-1(ok948);cnx-1(ok2234 );
ufIs42, IZ787 unc-29(x29);ufIs25, IZ928 acr-3(ok2049);ufIs265, IZ929
acr-5(ok180);ufIs25, IZ930 acr-9(ok933);ufIs25, IZ931 acr-19(ok967 );
ufIs25, IZ932 acr-23(ok2840);ufIs25,IZ446 unc-38(e264 );ufIs25, IZ659
unc-50(e306 );ufIs25, IZ921 unc-63(ok1075);ufIs25, IZ490 unc-68(e540);
ufIs25, IZ604 unc-74(e883);ufIs25, IZ673 acr-12(ok367 );ufIs25;ufEx148,
IZ937 acr-12(ok367 );ufIs25;ufIs60, IZ861 acr-12(ok367 );ufIs25;ufEx191.
Genetic screen and identification of suppressors of
ACR-2(L/S)-induced paralysis
Paralyzed animals expressing the integrated ACR-2(L/S) array (ufIs25)
were mutagenized with 50 mM ethyl methanesulfonate (Brenner, 1974).
Young adult F2 progeny of20,000 mutagenized animals were washed
twice withM9 and transferred to fresh plates. After allowing time for the
animals to disperse, moving animals were picked to single plates. Eighty-
one candidate suppressors were isolated. A secondary screen showed that
fifty-one of these were resistant to the paralyzing effects of levamisole.
For genetic complementation tests, males carrying a mutation in candi-
date levamisole-resistance genes were crossed with hermaphrodites car-
rying the ACR-2(L/S) transgene and a suppressor mutation. F1 progeny
were scored for paralysis. A cross was performed in parallel using N2
males to identify X-linked suppressor mutations and determine domi-
nance/recessivity. The mapping of acr-12 alleles was performed in the
presence of the ACR-2(L/S) transgene. A strain carrying the integrated
ACR-2(L/S) transgene (ufIs25) on linkage group I was backcrossed 7 to
the CB4856 Hawaiian strain. acr-12 alleles were mapped to a region the
right of 8 on the X chromosome using the SNP mapping procedure
described as previously (Wicks et al. 2001; Davis et al. 2005).
Behavioral assays
All behavioral analysis was performed with young adult animals (24 h
post-L4) at room temperature (22°C–24°C); different genotypes were
scored in parallel, with the researcher blinded to the genotype.
Aldicarb and levamisole assays. Staged populations of adult animals
(10) were transferred toNGMplates containing 1mM aldicarb (Chem-
Service), andmovementwas assessed every 15min for 2 h.Data represent
the mean  SEM of at least four assays. For levamisole assays, staged
populations of adult animals were scored for paralysis after 120 min on
plates containing 200 M levamisole.
Body bend analysis. Body bends were scored on unseeded NGM agar.
Animals were transferred from their culture plate to an unseeded plate
and allowed to crawl away from any food that might have been trans-
ferred. The animals were then gently transferred without food to another
unseeded plate and allowed to recover for 1 min. After the recovery
period, the animals were filmed for 5 min using an ImagingSource DMK
21F04 FireWire camera and iMovie software.
Microscopy
Confocal microscopy was performed using a Zeiss Axioskop 2 micro-
scope system and LSM Pascal 5 imaging software (Zeiss). Images were
processed using ImageJ software (open source). Epifluorescent imaging
was performed using a Zeiss Axioimager M1microscope and Axiovision
software (Zeiss). Movies and still images for behavioral analyses were
obtained using an Olympus SZ61 upright microscope equipped with a
FireWire camera (ImagingSource). For the developmental timeline, syn-
chronized populations were obtained by bleaching gravid animals on
NGM plates seeded with OP50. The resulting progeny were allowed to
mature at room temperature. Animals were imaged at 16, 28, 38, and 48 h
after bleaching using wide-field epifluorescent microscopy, and the
number of surviving cell bodies were counted manually with the re-
searcher blinded to genotype.
Results
acr-2 encodes a nicotinic receptor subunit expressed in
cholinergic motor neurons
TheC. elegans genome encodes 29 nAChR subunits that contrib-
ute to the formation of distinct classes of homopentameric and
heteropentameric receptors (Jones et al. 2007; Rand, 2007). Two
classes of nAChRs formed from six of these subunits are ex-
pressed in bodywallmuscle cells and required for neuromuscular
signaling (Richmond and Jorgensen, 1999; Francis et al. 2005;
Touroutine et al. 2005). Previous studies have suggested that the
expression of several nicotinic acetylcholine receptor subunits,
including the non- subunit acr-2, is enriched in motor neurons
of the ventral nerve cord (Hallam et al. 2000; Cinar et al. 2005;
Jospin et al. 2009). To determine which ventral cord motor neu-
rons express acr-2, we examined transgenic strains that expressed
GFP (Chalfie et al. 1994) under the control of acr-2 regulatory
sequences. Expression of Pacr-2::GFP was limited to the nervous
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system and largely restricted to neurons lo-
cated in the ventral nerve cord. Expression
ofPacr-2::GFPdidnot overlapwith expres-
sion of a GABAergic mCherry reporter
(Punc-47::mCherry), indicating that ex-
pression of acr-2 was limited to cholin-
ergicmotor neurons (DA, VA, DB, VB) in
the ventral nerve cord of adult animals
(Fig. 1A). To determine the subcellular
localization of ACR-2, we generated
transgenic strains that expressed a full-
length ACR-2::GFP fusion protein in
which GFP was inserted in frame in the
intracellular loop region located between
transmembrane domains three and 4 (Fig.
S1, available at www.jneurosci.org as sup-
plemental material). Expression of the
GFP reporter construct could be observed
at all larval stages and in the adult. We
noted the onset of expression in late
embryogenesis by the threefold stage
(550 min after fertilization). In first
larval stage (L1) animals, when DA and
DB motor neurons are the sole excita-
tory motor neurons present, ACR-2 ex-
pression was clearly visible in ventral
nerve cord processes. DA and DB motor
neuron dendrites receive synaptic input
in the ventral cord, and these neurons
extend commissural axons to the dorsal
cord where they form neuromuscular
synapses with the dorsal musculature.
In adult animals, we found that the fu-
sion protein was diffusely localized to
neuronal processes of the dorsal and
ventral nerve cords. Our analysis sug-
gests that ACR-2 is diffusely localized
with enriched expression in the dendritic compartment of
cholinergic motor neurons.
The locomotory control interneurons provide synaptic input
to the excitatory motor neurons; however, the role of acetylcho-
line (ACh) in this signaling remains unclear. To evaluate whether
the locomotory control interneurons are cholinergic, we exam-
ined transgenic strains that coexpressed GFP under control of
regulatory elements for the gene encoding the ACh vesicular
transporter (Punc-17::GFP) together with the red fluorescent
protein mCherry expressed under the control of the regulatory
elements for the nmr-1 gene (Pnmr-1::mCherry) (Figure S2,
available at www.jneurosci.org as supplemental material). nmr-1
is expressed in the AVA, AVD, AVE ,and PVC locomotory con-
trol interneurons, as well as the RIM and AVG neurons (Brockie
et al. 2001). We noted no overlap in the pattern of the red and
green fluorescent signals with the possible exception of the inter-
neuron AVE, indicating that these two reporters labeled almost
completely independent cell populations. These data are consis-
tent with the idea that the locomotory control interneurons are
not primarily cholinergic. The enriched expression of ACR-2 in
the dendritic compartment of motor neurons may reflect the
involvement of ACR-2 receptor complexes at synapses between
AVE and cholinergic motor neurons; however, the lack of
Punc-17::GFP expression in a majority of locomotory control
interneurons and the diffuse distribution of ACR-2 are inconsis-
tent with an exclusive role at synapses.
Figure 1. acr-2 is expressed in cholinergic motor neurons andmodulates motor neuron activity. A, Confocal image of the
posterior ventral nerve cord of an adult animal coexpressing a GABA-specific marker (Punc-47::mCherry) and an ACR-2-
specific marker (Pacr-2::GFP). No overlap is observed between GFP-expressing and mCherry-expressing neurons. The
animal is oriented with the posterior (tail) on the right. B, Quantification of movement on a food-free agar plate. Average
number of body bends per minute for wild type, acr-2(ok1887 ) mutants, and acr-2(ok1887 ) mutants expressing full-
length ACR-2::GFP (ufIs42) over a 5 min period are shown. Data represents mean SEM of at least 10 trials; **p 0.01
compared to wild type. C, Time course of paralysis in the presence of the cholinesterase inhibitor aldicarb (1 mM) for wild
type, acr-2(ok1887 ) mutants, and acr-2(ok1887 ) mutants expressing full-length ACR-2::GFP (ufIs42). The percentage of
immobilized animals calculated every 15 min over a time course of 2 h is shown. Each data point represents the mean
SEM of at least four trials. *p 0.001, two-way ANOVA.
Figure 2. Transgenic animals expressing the dominant ACR-2(L/S) transgene are severely
uncoordinated. A, B, Still image of a wild-type animal (A) and a transgenic animal expressing
the ACR-2(L/S) transgene (B). Note the coiled posture and reduced size that occurs as a result of
ACR-2(L/S) expression. C, Quantification ofmovement on a food-free agar plate. Average num-
ber of body bends per minute for wild type, acr-2(ok1887 ) mutants, and transgenic animals
expressing full-length ACR-2(L/S) (ufIs25) counted over a 5 min period are shown. Data repre-
sent mean SEM. of at least 10 trials; *p 0.02; **p 0.0001.
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acr-2mutants have motor deficits
The cholinergic motor neurons in the ventral nerve cord make
synaptic contacts onto the body wall musculature that drives
nematode locomotion. To evaluate the contribution of ACR-2 to
cholinergic motor neuron excitability and motor output, we ob-
tained a strain carrying a deletion mutation (ok1887 ) in the acr-2
genomic locus. The acr-2(ok1887) eliminates 2.8 kb of chromo-
somal DNA, including the transcriptional start, and is likely to be a
null. Animals homozygous for the ok1887 allele are healthy and
viable. acr-2(ok1887) mutants are not obviously uncoordinated,
though closer inspection revealed a modest
decrease in locomotion rate (Fig. 1B). Ex-
pression of the full-length ACR-2::GFP fu-
sion protein in acr-2(ok1887) mutants was
sufficient to restore normal movement.
The acetylcholinesterase inhibitor al-
dicarb has proven to be a useful tool for
detecting alterations in neurotransmitter
release from cholinergic motor neurons.
To test whether ACR-2 receptor com-
plexes may be important for regulating
activity of the cholinergic motor neu-
rons, we examined whether acr-2 mutant
worms exhibit altered sensitivity to the
paralyzing effects of aldicarb. acr-2 mu-
tant animals were slightly resistant to pa-
ralysis by aldicarb, and this effect was
normalized by expression of ACR-2::GFP
(Fig. 1C). These data are consistent with
the notion that ACR-2 plays a role in
modulating the activity of cholinergic
motor neurons but suggest that ACR-2 is
not absolutely required for motor neuron
depolarization.
Introducing a dominant mutation in
ACR-2 leads to profoundmotor deficits
The second transmembrane domains of
Cys-loop family ligand-gated ion channel
subunits are well known to line the ion
channel pore and play a critical role in
channel gating. In particular, a highly
conserved nonpolar residue (typically
leucine) in the M2 region has been shown
to have profound effects on receptor acti-
vation properties (Fig. S3, available at
www.jneurosci.org as supplemental ma-
terial). Substitution of a polar amino acid
(e.g., serine) for the leucine at this posi-
tion produces a gain-of-function effect,
resulting in increased receptor activation
and very slow inactivation (Revah et al.,
1991; Labarca et al. 1995).
We engineered the homologous
leucine-to-serine point mutation into the
sequence encoding the M2 9 position of
an acr-2 rescuing construct to generate
ACR-2(L/S) (Fig. S3, available at www.
jneurosci.org as supplemental material).
Transgenic animals expressing an inte-
grated ACR-2(L/S) array (ufIs25) were
used for all subsequent analyses. These
animals are viable and have roughly nor-
mal brood sizes; however, adult animals are smaller than their
wild-type counterparts (Fig. 2). Moreover, we noted obvious lo-
comotory defects in transgenic ACR-2(L/S) animals (Fig. 2C).
These defects were present in all larval stages as well as adult
animals. Transgenic ACR-2(L/S) animals generated almost ten-
fold fewer body bends than the wild type and failed to propagate
the sinusoidal wave that is typical of nematode movement, al-
though animals remained capable of head foraging movements.
The effects of ACR-2(L/S) were dominant, consistent with the
notion that the phenotypes arose as a consequence of expression
Figure 3. Transgenic expression of ACR-2(L/S) leads to a loss of cholinergic motor neurons. A, A1, DIC images of an adult wild
type animal (A) and an adult transgenic animal expressing ACR-2(L/S) (A1). Triangles denote lesions observed along the ventral
nerve cord of transgenic animals expressing ACR-2(L/S). Images showa region directly posterior of the vulva and are orientedwith
the ventral surface facing up and the anterior of the animal to the left. B, B1, Wide-field epifluorescent images of a transgenic
animal expressing the cholinergic neuronmarker Punc-17::GFP (vsIs48) (B) and a transgenic animal coexpressing ACR-2(L/S)with
Punc-17::GFP (B1). The fewPunc-17::GFP-labeledmotor neurons that remain in transgenic ACR-2(L/S) animals include the six VCs
(indicated) and amore variable group of10–12 neurons (arrowheads). C, C1, Wide-field epifluorescent images of a transgenic
animal expressing Punc-47::mCherry (C) and a transgenic animal coexpressing Punc-47::mCherry with ACR-2(L/S) (C1). The full
complement of Punc-47::mCherry-labeledmotor neurons remains in transgenic ACR-2(L/S) animals and is indicated. D, Quantifi-
cation of the total number ofmotor neurons inwild-type (gray) andACR-2(L/S) animals (black); *p0.01. For all images, animals
are positioned with the head on the left side of the image.
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of a gain-of-function receptor. Our results suggest that motor
output to head muscles is unaffected, while control of body wall
musculature is dramatically impaired in these animals.
ACR-2(L/S)-inducedmotor neuron degeneration
Examination of the ventral nerve cord region of transgenic ACR-
2(L/S) animals by differential interference contrast (DIC) mi-
croscopy showed that a subset of the ventral nerve cord neurons
that normally express acr-2 swelled beyond their normal diame-
ter and eventually disappeared, presumably as a result of cell
death (Figs. 3, 4). These results suggest that enhanced cholinergic
signaling mediated by receptors incorporating ACR-2(L/S) leads
to motor neuron toxicity. To characterize this in more detail, we
examined the effects of ACR-2(L/S) expression in strains carrying
fluorescent reporters that label populations of cholinergic neu-
rons.We observed only dim Pacr-2::GFP fluorescence in the ven-
tral nerve cord of ACR-2(L/S) animals, suggesting that many of
the neurons labeled by this reporter were lost (data not shown).
To evaluate the specificity of this effect for neurons that expressed
acr-2, we examined a Punc-17::GFP reporter that is expressed in
all cholinergic neurons (Fig. 3) (Chase et al. 2004). While ACR-
2(L/S) expression did not produce obvious differences in the
number of head neurons labeled by Punc-17::GFP, we observed a
dramatic decrease in the number of ventral nerve cord motor
neuron cell bodies; yet, several motor neuron cell bodies re-
mained present. The surviving neurons included the six VC mo-
tor neurons that do not normally express acr-2 and a more
variable group of 10–12 additional excitatory motor neuron cell
bodies (Figs. 3; Fig. S4, available at www.jneurosci.org as supple-
mental material). Based on the position and number of cell bod-
ies and commissural processes, the additional surviving neurons
included both DA and DB motor neurons that normally express
acr-2, as well as AS motor neurons that do not. Similar to our
observations for ACR-2(L/S)-induced paralysis, the effects of
ACR-2(L/S) on motor neurons were dominant. To evaluate the
effects of ACR-2(L/S) on GABA motor neurons, we coexpressed
ACR-2(L/S) together with a mCherry transcriptional reporter
that labeled GABA neurons (Punc-47::mCherry) (Fig. 3C,D).We
observed that the full complement of GABA neurons was present
and morphologically normal. These data suggest that ACR-
2(L/S) acts cell autonomously to promote degeneration of motor
neurons and that specific neurons are differentially susceptible to
the effects of ACR-2(L/S) expression.
Motor neuron loss occurs soon after onset of
ACR-2(L/S) expression
As noted above, we observed clear ACR-2::GFP fluorescence in
late embryogenesis. We found that threefold embryos coexpress-
ing ACR-2(L/S) with the Pacr-2::GFP transcriptional reporter
possessed normal numbers of GFP-positive neurons, suggesting
that ACR-2(L/S) toxicity occurred after hatch (Fig. S4, available
at www.jneurosci.org as supplemental material). To precisely de-
termine the onset of motor neuron cell death, we imaged trans-
genic ACR-2(L/S) animals that coexpressed the Punc-17::GFP
transcriptional reporter at various time points ranging from
newly hatched larvae to adults (Fig. 4). We observed significant
motor neuron loss in newly hatched larvae. Roughly 40% of the
16 cholinergic motor neurons present in L1 animals were lost
within 16 h after hatch. During the transition from the first larval
stage to the second larval stage (L2) the number of ventral nerve
cord motor neurons increases substantially, with the addition of
50 motor neuron cell bodies (Sulston and Horvitz, 1977). In
transgenicACR-2(L/S) animalswe observed only a slight increase
in the number of cell bodies labeled by Punc-17::GFP over the
course of development. Even by the time transgenic ACR-2(L/S)
animals had clearly reached adulthood, the number of
Figure 4. ACR-2(L/S)-induced motor neuron cell death is initiated before hatch. A, B, Wide-field epifluorescent images of wild-type (A) and transgenic ACR-2(L/S) (B) animals expressing
Punc-17::GFP imaged 16, 28, 38, and 48 h after bleach synchronization of embryos. C, D, Confocal images of first larval stage wild-type (C) and transgenic ACR-2(L/S) (D) animals expressing
Punc-17::GFP. Swollen or dying neuronal cell bodies are indicated (arrowheads). E, Quantification of the average number of cell bodies at the time points indicated for wild type (black bars) and
transgenic ACR-2(L/S) animals (gray bars). Bars represent the mean SEM for 5–8 animals at each time point.
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Punc-17::GFP labeled motor neuron cell bodies was roughly
comparable to that of a wild-type L1 animal. The VC motor
neurons do not express acr-2 and are clearly present in transgenic
ACR-2(L/S) animals (Fig. 3; Fig. S5, available at www.jneurosci.
org as supplemental material). Therefore, the small developmen-
tal increase in the number of motor neuron cell bodies that we
observe in transgenic ACR-2(L/S) animals likely represents the
postembryonic addition of VC neurons. These results suggest
that the other classes of motor neurons that are born postembry-
onically and normally express acr-2 (e.g., VA, VB) are almost
completely absent in adult transgenic ACR-2(L/S) animals.
Mutations that suppress paralysis define the subunits of a
neuronal nAChR
To identify genes required for the toxic effects of transgenic ACR-
2(L/S) expression, we conducted a forward genetic screen for
suppressors of ACR-2(L/S)-induced paralysis. We screened the
F2 progeny ofmutagenized hermaphrodites that expressed ACR-
2(L/S) and selected animals that exhibited improved movement.
A close examination of the mutants isolated from the screen
showed that two phenotypic classes were easily distinguishable.
One class of animals phenocopied strains that lack a well charac-
terized heteromeric nAChR that mediates excitatory signaling at
the neuromuscular junction (NMJ) and is a principal target of the
antihelminthic drug levamisole (L-AChR). We found that mem-
bers of this class were strongly levamisole-resistant, and we iso-
lated alleles of the levamisole resistance genes unc-38, unc-63,
unc-74, and unc-50 from these animals (supplemental Table S1,
available at www.jneurosci.org as supplemental material). We
also crossed available strains carrying single loss-of-function
mutations in known levamisole resistance genes with transgenic
ACR-2(L/S) animals (Table 1). Consistent with the results from
our forward genetic approach, loss-of-function mutations in ei-
ther unc-38, unc-63, unc-74, or unc-50were sufficient to suppress
ACR-2(L/S) toxicity and restore movement (Fig. 5A). Interest-
ingly, we also found that unc-29, a non- subunit required for
L-AChR function, was not required for ACR-2(L/S)-induced pa-
ralysis. Likewise, acr-16, an essential subunit of homomeric
nAChRs at the NMJ, was not required for ACR-2(L/S)-induced
paralysis. unc-38 and unc-63 encode nAChR  subunits that are
required for L-AChR function at the NMJ but are also expressed
in the nervous system (Fleming et al. 1997; Culetto et al. 2004;
Eimer et al. 2007). unc-50 and unc-74 encode genes previously
implicated in L-AChR maturation and are broadly expressed in
muscles and neurons. Our analysis suggests that each of these
gene products may contribute in a cooperative fashion to the
generation of functional ACR-2(L/S) receptors and subsequent
toxicity.
A smaller number of animals isolated from the screen exhib-
ited uncoordinatedmovementwith deep body bends and showed
normal sensitivity to the paralyzing effects of levamisole. We de-
termined that the suppressor mutations in this second pheno-
typic class represented one complementation group and were X
linked. Using single-nucleotide polymorphism mapping, we
mapped one allele to the right of8 on the X chromosome. The
nAChR subunit gene acr-12 is located in this genomic region.
Sequence analysis revealed four nonsense mutations and two
missense mutations in the acr-12 coding sequence among our
second class of suppressors (Fig. 5B). We also found that a dele-
Figure 5. Mutations in nicotinic acetylcholine receptor subunits suppress ACR-2(L/S)-
induced paralysis. A, Quantification of the average number of body bends per minute for wild-
typeanimals,acr-12(ok367 ),unc-63(ok1075),unc-38(e264 ),unc-74(e883), andunc-50(e306 )
mutants in the absence (gray bars) or presence (black bars) of the ACR-2(L/S) transgene. Ani-
mals were placed on a food-free agar plate, and the average number of body bends perminute
was quantified over a 5min period. Data represent themean SEM. of at least 10 animals for
each genotype. B, Schematic of themembrane topology of ACR-12with approximate location,
allele names, and molecular nature of loss-of-function mutations that suppress ACR-2(L/S)
toxicity indicated. C, Quantification of the average number of body bends per minute for the
following genotypes: wild type, acr-12(ok367 ), transgenic ACR-2(L/S), acr-12 mutants ex-
pressing ACR-2(L/S), acr-12 mutants expressing ACR-2(L/S) together with an extrachromo-
somal array containing Punc-47::ACR-12, and acr-12mutants expressing ACR-2(L/S) together
with an extrachromosomal array containing the Pacr-2::ACR-12 cDNA. Data represent the
mean SEM. for 5–10animals.D–H, Still images of adult animals onNGMplateswithout food
for the genotypes indicated. “GABA” and “ACh” refer to specific expression of the acr-12 cDNA in
GABAergic or cholinergic neurons using the unc-47 or acr-2 promoters, respectively.
Table 1. Several nAChR subunits are required for ACR-2(L/S)-induced paralysis
Gene ACR-2(L/S) suppression Description
acr-2(ok1887)  nAChR non- subunit
acr-3(ok2049)  nAChR non- subunit
acr-5(ok180)  nAChR subunit
acr-9(ok933)  nAChR non- subunit
acr-12(ok367)  nAChR subunit
acr-14(ok1155)  nAChR subunit
acr-15(ok1214)  nAChR subunit
acr-16(ok789)  nAChR subunit
acr-19(ok967)  nAChR subunit
acr-23(ok2840)  nAChR subunit
unc-63(x37)  nAChR subunit
unc-38(e264)  nAChR subunit
unc-29(x29)  nAChR non- subunit
unc-50(e306)  Golgi integral membrane protein
unc-74(e883)  Function unknown
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tion mutation (ok367) in the acr-12 gene
suppressed paralysis in transgenic ACR-
2(L/S) animals and prevented the loss of
motor neuron cell bodies. Expression of a
full-length acr-12 rescuing construct in
acr-12(ok367);ACR-2(L/S) animals re-
stored paralysis, verifying that acr-12 is re-
quired (Fig. 5C,F). In contrast, we found
that several other nAChR subunits with
restricted expression to the nervous sys-
tem were not required for ACR-2(L/S)-
induced paralysis (Table 1). acr-12
encodes a nicotinic receptor  subunit
that is broadly expressed in the nervous
system, including many ventral cord mo-
tor neurons, but is not expressed in body
wallmuscles (Cinar et al. 2005; Gottschalk
et al. 2005). acr-12(ok367) mutants have
grossly normal movement and show nor-
mal sensitivity to the paralyzing effects of
levamisole. To test whether acr-12 expres-
sion solely in cholinergic motor neurons
is sufficient for ACR-2(L/S)-induced tox-
icity, we specifically restored expression of
acr-12 to either ACh orGABAmotor neu-
rons of acr-12(ok367) mutants that car-
ried the ACR-2(L/S) transgene (Fig. 5C–
H). We found that-specific expression of
the acr-12 cDNA in cholinergic motor
neurons of transgenic acr-12(ok367);
ACR-2(L/S) mutants led to ACR-2(L/S)
toxicity and paralysis. In contrast, specific
expression in GABA neurons had no effect.
Our results indicate that acr-12 expression
in cholinergic motor neurons is specifically
required for ACR-2(L/S)-induced cell
death. Furthermore, our results suggest that
coassembly of ACR-2(L/S) into a hetero-
meric receptor complex with UNC-38,
UNC-63, and ACR-12 is required to produce toxicity.
ACR-2(L/S)-inducedmotor neuron
loss is suppressed in cnx-1;crt-1 double mutants
At least twomechanistically distinct types of cell death have been
described. Programmed cell death or apoptosis is a form of cell
death common in development and tissue homeostasis and oc-
curs by a genetic program that is broadly conserved across meta-
zoans (Danial and Korsmeyer, 2004). Necrosis generally occurs
following cellular injury and is often characterized by swelling of
the dying cell (Festjens et al. 2006; Golstein and Kroemer, 2007).
Our forward genetic screen did not identify genes previously im-
plicated in the execution of either of these forms of cell death. To
determine how ACR-2(L/S) expression leads to cell death, we
introduced the ACR-2(L/S) transgene into genetic backgrounds
deficient for genes essential for either apoptotic cell death or
necrotic cell death (Fig. 6). We found that a loss-of-function
mutation in proapoptotic ced-3 (Ellis and Horvitz, 1986) or a
gain-of-function mutation in anti-apoptotic ced-9 (Hengartner
et al. 1992) had no effect on ACR-2(L/S)-induced deaths. Thus,
the programmed cell death machinery is not required for
ACR-2(L/S)-induced neurodegeneration.
Dysregulation of intracellular calcium levels contributes to
cell death under a variety of circumstances, including necrotic
cell death (Mattson et al. 2000; Rao et al. 2004; Szydlowska and
Tymianski, 2010). Calreticulin/CRT-1 and calnexin/CNX-1 are
endoplasmic reticulum (ER) resident proteins that serve dual
functions as Ca2 binding proteins and molecular chaperones
that facilitate glycoprotein folding (Ellgaard and Frickel, 2003).
In mice, loss of either calnexin or calreticulin produces severe
phenotypes: calnexin knock-out mice die within 4 months of
birth, while knock-out of calreticulin results in embryonic lethal-
ity caused by defects in heart development (Mesaeli et al. 1999;
Denzel et al. 2002). In C. elegans, crt-1 and cnx-1 single mutants
are viable, and loss-of-function mutation in the crt-1 gene or
RNA interference knockdown of cnx-1 expression suppresses
several cases of ion channel-mediated cell death (Xu et al. 2001).
We found that the deletion mutation cnx-1(ok2234) had no sig-
nificant effect on ACR-2(L/S)-induced cell death, whereas the
deletion mutation crt-1(ok948) partially suppressed the loss of
motor neurons observed in transgenic ACR-2(L/S) animals.
Neither of these mutations led to significant locomotory
improvement.
As calnexin and calreticulin perform similar cellular func-
tions, we generated a strain carrying loss-of-function mutations
in both genes to test whether they may act redundantly in ACR-
2(L/S)-induced toxicity. cnx-1;crt-1 double mutants were viable
although smaller in size than wild-type animals, had grossly nor-
Figure 6. ACR-2(L/S)-mediated motor neuron loss is completely prevented in animals doubly mutant for calnexin and calreti-
culin. A–F, Representative wide-field images of Punc-17::GFP fluorescence in the ventral nerve cord of adult animals for the
genotypes indicated. For each image the head is oriented to the left. The alleles used were ced-3(ok2734 ), cnx-1(ok2234 ), and
crt-1(ok948).G, Quantification of the average number of Punc-17::GFP-labeled cell bodies present in the ventral nerve cord for the
genotypes indicated. Data represent themean SEM for at least 10 animals per genotype. * p 0.01, **p 0.01, compared to
transgenic ACR-2(L/S) animals.
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mal movement, and did not show obvious defects in nervous
system connectivity. While ACR-2(L/S) expression in wild-type
animals or cnx-1 and crt-1 single mutants caused paralysis across
all developmental stages, we found that first larval stage cnx-1;
crt-1 doublemutants expressing ACR-2(L/S) were often capable
of grossly normal locomotion (Fig. 7A,B,H). We also observed
that the full complement of 16 cholinergic
motor neuron cell bodies was present in
L1 cnx-1;crt-1;ACR-2(L/S) animals, and
we did not detect obvious defects in the
connectivity of the cholinergic motor
neurons (Fig. 7C). These results indicate
that embryonic born motor neurons de-
veloped normally and made appropriate
synaptic contacts onto their partner mus-
cle cells, suggesting that the combined
loss of crt-1 and cnx-1 is strongly neuro-
protective againstACR-2(L/S) toxicity inL1
animals. We observed that adult cnx-1;crt-1
doublemutants expressingACR-2(L/S)also
possessed normal numbers of cholinergic
motor neuron cell bodies, providing addi-
tional evidence that the presence of either
calnexin or calreticulin is required for the
cellular events that lead to ACR-2(L/S)-
induced cell deaths (Figs. 6F,G, 7D). How-
ever, larvae that had progressed beyond L1
and adult cnx-1;crt-1;ACR-2(L/S) animals
were unable to propagate sinusoidal body
bends and move effectively. This observa-
tion suggested that ACR-2(L/S) expression
in cnx-1;crt-1 double mutants led to a pro-
gressive disruption of motor function even
whenmotor neuron death was attenuated.
To determine whether altered motor
neuron connectivity may underlie the pa-
ralysis of adult cnx-1;crt-1;ACR-2(L/S)
animals, we made a close examination of
the cholinergic motor neuron processes
(Fig. 7E–G,I). We found that defects in
the motor neuron processes of control
cnx-1;crt-1 double mutants occurred only
rarely (Fig. S6, available at www.jneurosci.
org as supplemental material), and these
animals exhibited grossly normal move-
ment across all stages of development. In
cnx-1;crt-1 doublemutants that expressed
ACR-2(L/S), we observed defasciculation
of the ventral nerve cord neuronal pro-
cesses (in 96% of animals scored; n	 30),
as well as defects in the morphology of
commissural axons (in 75% of axons)
(Fig. 7). We often observed several classes
of defects within individual animals and,
in some instances, individual commis-
sural axons contained multiple defects.
The defects were of several types. First,
we observed abnormal axon branches
that often terminated in growth cone-
like structures (54% of animals). Sec-
ond, we observed ectopic sprouting
with no clear single axonal process
present (71% of animals). Finally, we
observed axons with abnormal trajectories and wandering
growth (83% of animals). These results suggest that themuscle
targets of cholinergic motor neuron processes are not appro-
priately innervated in adult animals. We observed that the
frequency of these defects increased dramatically after the first
larval stage (Fig. 7I ), suggesting that a progressive deficiency
Figure 7. Progressive destabilization of motor neuron processes in cnx-1;crt-1;ACR-2(L/S) animals. A, B, Frames showing the
movement of L1 transgenic ACR-2(L/S) (A) or cnx-1;crt-1;ACR-2(L/S) (B) animals 30 s (t	 0), 60 s (30), or 90 s (60) after
transfer to an agar plate. The black arrow marks the starting positions of the worms in each frame. The transgenic ACR-2(L/S)
animal does not move from where it was placed on the plate. The dashed line shows the movement path of the L1 cnx-1;crt-1;
ACR-2(L/S) animal over the course of 60 s. The additional tracks on the plate show the path of the animal in an30 s period before
imaging began. C, D, Confocal images of a first larval stage (C) or adult cnx-1;crt-1;ACR-2(L/S) animals expressing an integrated
Punc-17::GFP (D). Images show Z-projections of 15 confocal planes (0.5m/slice) (C) or 16 confocal planes (0.5m/slice) (D).
Arrows (D) indicate positions of commissures. Dashedbox (D) indicates areawithmultiple neuronal defects.E–G, Confocal images
of cnx-1;crt-1;ACR-2(L/S) animals taken at hatch (E), 24 h posthatch (F ), and adulthood (G). In each case, a region immediately
posterior of the vulva was imaged and the ventral nerve cord is positioned at the top. Arrows indicate commissural processes;
arrowheads indicate the ventral nerve cord. Images show Z-projections of 12 confocal planes (E), 23 confocal planes (F ), or 33
confocal planes (G) (0.5m/slice). Scale bars represent 10m. H, Quantification of percentage of animals moving at hatch in
ACR-2(L/S) and cnx-1;crt-1;ACR-2(L/S) animals. Data represent the mean number of animals SEM making more than two
consecutivebodybendsduringa3minperiod. I, Quantificationof thepercentageof cnx-1;crt-1and cnx-1;crt-1;ACR-2(L/S) animals
with defective neuronal process morphology. Observed defects include defasciculation of the ventral nerve cord, wandering
commissural processes, or ectopic branching.
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in the stabilization or maintenance of appropriate neuromus-
cular connectivity underlies the paralysis we observed in ma-
ture animals.
To better understand the mechanisms underlying the sup-
pression of ACR-2(L/S)-mediated cell death in cnx-1;crt-1 ani-
mals, we directly evaluated the role of intracellular calcium. We
found that culturing transgenic ACR-2(L/S) animals in the pres-
ence of dantrolene, an inhibitor of ER calcium release, or the
calcium chelator EGTA (Fig. 8A,B) led to a modest but signifi-
cant increase in the number of surviving motor neuron cell bod-
ies. Similarly, we observed reducedACR-2(L/S) toxicity inunc-68
mutants lacking functional ryanodine receptors (Fig. 8C). These
results provide evidence that intracellular calcium signaling con-
tributes to cell death in ACR-2(L/S) animals and support the idea
that altered intracellular calcium in cnx-1;crt-1 double mutants
may likewise contribute to the neuroprotection we observed. To
test whether altered expression of ACR-2(L/S) in cnx-1;crt-1 dou-
blemutantsmay also be a contributing factor, wemeasured levels
of ACR-2::GFP fluorescence. We observed an approximately
twofold decrease in ACR-2::GFP fluorescence in both the cell
bodies and ventral nerve cord of cnx-1;crt-1 double mutant ani-
mals compared to wild-type animals (Fig. 8D–G). This result
suggests that a decrease in the levels of ACR-2(L/S) in cnx-1;crt-1
animals also contributes to the neuroprotection we observe.
Discussion
Our analysis of ACR-2-containing nicotinic receptors in C.
elegans neurons has revealed common features between the func-
tion of these receptors in the C. elegans nervous system and roles
for heteromeric nAChRs in the vertebrate brain (Dani and
Bertrand, 2007). First, heteromeric nAChRs in the mammalian
brain are not primarily concentrated at postsynaptic sites; instead,
they are more variably localized to presynaptic, preterminal, and
nonsynaptic sites. Similarly, we find that ACR-2-containing
nAChRs appear diffusely localized to the processes of excitatory
motor neurons, suggesting that these receptors may function at
extrasynaptic sites. Second, heteromeric brain nAChRs primarily
function to modulate neurotransmitter release and neuronal ex-
citability. Our studies of acr-2 loss-of-function mutants indicate
that heteromeric nAChRs containing ACR-2modulate the excit-
ability of cholinergic motor neurons but are not absolutely re-
quired for motor neuron depolarization or ACh release at
neuromuscular synapses. Third, mouse studies have shown that
knock-in expression of a heteromeric brain nAChR subunit bear-
ing a L/S pore modification homologous to the one we describe
here causes dramatic neuron loss and perinatal lethality (Labarca
et al. 2001). Likewise, transgenic expression of ACR-2(L/S) leads
to cell-autonomous neurodegeneration.
Importantly, our transgenic approach also enabled us to iden-
tify genes required for ACR-2(L/S) toxicity. Mutations that sup-
pressed both the paralysis and neurodegeneration caused by
ACR-2(L/S) expression defined the constituent subunits of a pu-
tative multimeric ACR-2 receptor complex as well as genes re-
quired for receptor trafficking and assembly. Additionally, a
single genemutation in crt-1, previously shown to suppress other
forms of ion channel-mediated cell death in C. elegans, partially
suppressed ACR-2(L/S) toxicity.We found that the loss of motor
neurons caused by ACR-2(L/S) expression was completely sup-
pressed in adult cnx-1;crt-1 double mutants; yet, these animals
remained paralyzed. Interestingly, suppression of ACR-2(L/S)-
induced cell death uncovered a secondary consequence of ACR-
2(L/S) expression: the accumulation of morphological defects in
the processes of surviving motor neurons. These axonal defects
resemble outgrowth errors typically associated with secondary
regrowth of axons (Knobel et al. 2001; Hammarlund et al. 2007).
Therefore, the severe morphological defects we observed in adult
animals may reflect inappropriate regrowth subsequent to desta-
bilization.We propose that the necrotic-like cell death and desta-
bilization of neuronal processes observed in our studies may
represent genetically separable events and suggest that our trans-
genic approach may afford a powerful system to tease apart the
molecular pathways that differentially contribute to these two
processes.
ACR-2 is part of a heteromeric nAChR in cholinergic
motor neurons
We have demonstrated that acr-2 shows restricted expression to
cholinergic motor neurons of the ventral nerve cord and appears
diffusely localized in neuronal processes. These results suggest
that the ACR-2 receptor complex may modulate motor neuron
excitability by mediating signaling at extrasynaptic sites. Consis-
tent with this notion, acr-2 loss-of-function mutants are not
grossly uncoordinated and show only modest resistance to the
paralyzing effects of the ACh esterase inhibitor aldicarb.
Aldicarb-induced paralysis arises as a consequence of the pro-
longed action of ACh in the synaptic cleft; our analysis suggests
that ACh release from motor neurons is decreased in acr-2 mu-
tants. Another recent study reached a similar conclusion based on
Figure 8. Perturbation of intracellular calcium and reduced ACR-2::GFP levels in cnx-1;crt-1
doublemutants suggest dualmechanisms for cell death suppression.A–C, Quantification of the
average number of Punc-17::GFP-labeled cell bodies present in the ventral nerve cord in adult
animals treatedwith dantrolene (A), L1 animals treatedwith EGTA (B), and adult unc-68(e540)
mutant animals (C). Data represent the mean SEM. for at least eight animals. **p 0.01,
***p 0.01, compared to untreated ACR-2(L/S) animals. D, E, Confocal images of adult wild
type (D) or cnx-1;crt-1 (E) animals expressingACR-2::GFP. Imagesaretakenimmediatelyposterior
to the vulva and show Z-projections of seven confocal planes (0.5m/slice). F, G, Quantification of
fluorescence levels in cell bodies (F ) andventralnervecordprocesses (G) ofwild-typeandACR-2(L/S)
animals transgenically expressing ACR-2::GFP. Data represent themean SEM. for at least 10 ani-
mals. ***p 0.01, compared toACR-2(L/S) animals.
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electrophysiological analysis of acr-2 loss-of-function mutants
(Jospin et al. 2009). We also show that the locomotory control
interneurons (with the possible exception of AVE)—the major
source of synaptic inputs to excitatory motor neurons—do not
express a reporter that labels cholinergic neurons, suggesting
these neurons are unlikely to be cholinergic. Therefore, what is the
source of ACh for activation of ACR-2 receptor complexes? The
presynaptic ACh release sites of en passant neuromuscular synapses
are highly intermingled and densely packed because of the inter-
calation of neuronal processes in the nerve cord. Thus, one pos-
sibility is that these receptors are activated by spillover of ACh
from release sites at nearby neuromuscular synapses.
Our genetic analysis showed that mutations in three genes
encoding AChR subunits can suppress the neurotoxic effects as-
sociated with expression of pore-modified ACR-2(L/S) recep-
tors. unc-38 and unc-63 are highly expressed in ventral cord
motor neurons and also contribute to a heteromeric receptor
complex that mediates excitatory neurotransmission at the NMJ
(Fleming et al. 1997; Culetto et al. 2004). acr-12 is broadly ex-
pressed in the nervous system but is not expressed in body wall
muscles (Cinar et al. 2005; Gottschalk et al. 2005). Our data are
consistent with the notion that UNC-38, UNC-63, and ACR-12
coassemble with the ACR-2 subunit [either native ACR-2 or
transgenic ACR-2(L/S)] to form heteromeric nAChRs in cholin-
ergic motor neurons (Jospin et al. 2009). Loss-of-functionmuta-
tions in any of these genes impair assembly or function of ACR-2
receptor complexes in cholinergic motor neurons and suppress
ACR-2(L/S)-induced cell death. Several pieces of evidence sup-
port this idea. First, mutations in unc-29 and acr-16—genes that
contribute to nAChRs at theNMJ and are essential for normal exci-
tatory neurotransmission at neuromuscular synapses (Richmond
and Jorgensen, 1999; Francis et al. 2005; Touroutine et al.
2005)—do not suppress ACR-2(L/S) neurotoxicity, indicating that
reduced excitatory neuromuscular signaling alone is insufficient to
suppress ACR-2(L/S)-induced toxicity. Second, specific expression
of acr-12 in the cholinergicmotor neurons of transgenic acr-12mu-
tants expressing ACR-2(L/S) was sufficient to produce paralysis,
whereas specific expression of acr-12 in other neuron classes was
without effect.Third, it has recentlybeen shownthat coexpressionof
five subunits—ACR-2, ACR-12, UNC-38, UNC-63, and ACR-3—
was required for reconstitution of ACR-2 receptor complexes in a
heterologous system (Jospin et al. 2009).
Pore-modified ACR-2(L/S) receptors cause ion
channel-mediated neurotoxicity
We have shown that expression of the ACR-2(L/S) transgene
leads to degeneration of the cholinergic motor neurons and pa-
ralysis, reinforcing the importance of these neurons in generating
sinusoidal movement. The GABA motor neurons develop nor-
mally even in the absence of ACh motor neurons, their major
source of synaptic input, indicating that the toxic effects of ACR-
2(L/S) expression are cell autonomous.We found thatmutations
in genes that are essential for the formation of functional ACR-2
heteromeric receptors suppress this effect, consistent with the
idea that excessive receptor activity leads to neurodegeneration.
Our results suggest that the level of receptor activity is a critical
determinant in the progression toward necrotic cell death. Con-
sistent with this idea, a less severe gain-of-function acr-2 allele
leads to cellular hyperexcitability without obvious loss of motor
neurons (Jospin et al. 2009). Interestingly, mouse studies using
knock-in expression of similarly pore-modified heteromeric
nAChR subunits have reported qualitatively similar degeneration
as a consequence of excess receptor activation (Orr-Urtreger et al.
2000; Labarca et al. 2001; Orb et al. 2004). Knock-out of Lynx1,
an endogenous negative regulator of nAChR function in the
mouse brain, also leads to a similar form of vacuolating degener-
ation that is exacerbated by nicotine (Miwa et al. 2006).
Release of calcium from internal stores plays a major a role in
many forms of cell death, including some forms of ion channel-
mediated toxicity. Pharmacological or genetic manipulation of
intracellular calcium levels led to a modest suppression of ACR-
2(L/S)-induced toxicity, providing evidence that calcium plays
an important role. However, ACR-2::GFP fluorescence was de-
creased substantially in cnx-1;crt-1 double mutants, suggesting
that a reduction in protein levels of the toxic transgene also con-
tributes to suppression of cell death. Similar to the case for ACR-
2(L/S) expression, cell death because of a gain-of-function
mutation in another C. elegans nAChR subunit, DEG-3, is not
suppressed by a single gene mutation in crt-1 (Treinin and
Chalfie, 1995; Xu et al. 2001; Syntichaki et al. 2002). Our findings
suggest that a requirement for genes additional to crt-1may be a
common feature of nAChR-mediated neuronal death that is dis-
tinct from cell death caused by hyperactive Na channels such as
MEC-4(d).
Inmousemodels ofmotor neuron disease, such as progressive
motor neuronopathy ( pmn) or the transgenic SOD1 G93A
model of amyotrophic lateral sclerosis, apoptosis of neuronal cell
bodieswas blocked by expression of the anti-apoptotic Bcl-2 gene
or knock-out of the proapoptotic Bax gene (Sagot et al. 1995;
Gould et al. 2006). In each case, degeneration of the neuronal
processes continued unimpeded and disease progression was un-
affected. ACR-2(L/S)-induced cell death clearly occurs indepen-
dently of the apoptotic pathway.However, it is interesting to note
that we also observe a progressive destabilization of the motor
neuron processes that leads to paralysis even under conditions
when death of the cell body is attenuated. Therefore, NMJ dener-
vation that occurs independently of the death of neuronal cell
bodies is the dominant feature shared across each of these cases.
In the future, it will be interesting to uncover the molecular
events leading to degeneration of the neuronal processes and
determine whether elements of the degenerative process are con-
served across these diverse models.
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